Your session is about to expire
← Back to Search
Shoulder Stabilization Surgery for Shoulder Dislocation (OASIS Trial)
OASIS Trial Summary
This trial will compare 3 surgical procedures and post-op rehab for people with shoulder instability and some glenoid bone loss. The goal is to help them return to military duty, work, and sports.
OASIS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowOASIS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.OASIS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 17 and 50 years old.You do not plan to return to the same level of work, sports, or military duty as before your injury.My joints are unstable in many directions without any injury causing it.I have had surgery or issues with my shoulder's rotator cuff.I do not have a serious shoulder injury.I have had a shoulder dislocation due to injury.I have a blood vessel injury related to shoulder injury.I can follow post-surgery instructions despite my brain injury.My shoulder injury is too severe to be fixed with bone surgery alone.I have a condition that affects my muscle control or causes seizures.
- Group 1: Arthroscopic Bankart repair with remplissage of Hill-Sachs lesion/rehabilitation
- Group 2: Open Bankart/rehabilitation
- Group 3: Latarjet/rehabilitation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the upper age limit of this trial extend beyond eighty five years?
"The study's criteria for admission states that those hoping to join must be between 17 and 50 years old."
How many participants are accepted into this trial at its peak capacity?
"Correct. According to the clinicaltrials.gov website, this research effort was first published on January 24th 2022 and is currently recruiting participants. 400 individuals need to be enrolled at 12 distinct medical institutions."
What specific goals are researchers attempting to achieve with this experiment?
"The primary endpoint for this investigation, observed over a period of 24 months post randomization, is the Western Ontario Shoulder Instability Index (WOSI). Secondary outcomes include Single Assessment Numerical Evaluation (SANE), Brophy Shoulder Activity Level and Patient-Reported Outcome Measurement Information System (PROMIS) Physical Function - Upper Extremity. The SANE scale boasts excellent reliability with an ICC greater than 0.80; validity displays moderate to strong correlations ranging between 0.50 and 0.88 compared to other patient reported outcome measures while its Standard Error of Measurement ranges from 4.23 to 7.82"
What is the extent of hospital involvement in this clinical trial?
"The current study has sites in Providence, Charlottesville, and Vail. Additionally, there are 12 other clinical trial sites operating for this research project."
Is this particular trial actively seeking participants?
"As indicated on clinicaltrials.gov, enrollment for this medical trial is currently ongoing. The study was first advertised on the 24th of January 2022 and its most recent update was made available on September 9th 2022."
Which demographic would most benefit from enrolling in this clinical investigation?
"This clinical trial aims to recruit 400 individuals between 17 and 50 years old that present with shoulder dislocation. Additionally, the candidate must have a bone loss of 10-20% lower than glenoid width as quantified by standard CT scan imaging technology. This study is open to both civilians and military personnel."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger